Resistant Cancer Clinical Trials in Chapel Hill, North Carolina
2 recruitingChapel Hill, North Carolina
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells
Breast CancerRelapseResistant Cancer
UNC Lineberger Comprehensive Cancer Center42 enrolled1 locationNCT06347068
Recruiting
Phase 1
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Pancreas CancerRelapseResistant Cancer
UNC Lineberger Comprehensive Cancer Center27 enrolled1 locationNCT06158139